Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

21.38 -0.20 (-0.95%)
Streaming Delayed Price Updated: 12:40 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
3 Reasons TNDM is Risky and 1 Stock to Buy Instead
Over the last six months, Tandem Diabetes’s shares have sunk to $22.45, producing a disappointing 13.7% loss - a stark contrast to the S&P 500’s 10.5% gain. ... 
Via StockStory
Topics Stocks
News headline image
Tandem Diabetes Care Maps Growth Plan With Pharmacy Shift and Tubeless Mobi ↗
Tandem Diabetes Care (NASDAQ:TNDM) highlighted its plans to expand insulin pump adoption through a shift to pharmacy distribution in the U.S., direct sales in additional international markets and... 
Via MarketBeat
News headline image
Tandem Diabetes (TNDM) Q2 2026 Earnings Call Transcript ↗
Pump shipments surged 10% as pharmacy adoption accelerated. 
Via The Motley Fool
Topics Earnings
Tandem Diabetes Care (NASDAQ:TNDM) Surges 10% After Q1 Beat on Revenue and Earnings ↗
Via Chartmill
News headline image
5 Must-Read Analyst Questions From Tandem Diabetes’s Q2 Earnings Call
Tandem Diabetes met Wall Street’s revenue and profit expectations in Q2, but the market responded negatively, likely reflecting investor caution around the p... 
Via StockStory
Topics Earnings
News headline image
Why Tandem Diabetes (TNDM) Stock Is Trading Up Today
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 18.2% in the afternoon session after the company reported seco... 
Via StockStory
Topics Artificial Intelligence
News headline image
Tandem Diabetes Care Q2 Earnings Call Highlights ↗
Tandem Diabetes Care (NASDAQ:TNDM) reported second-quarter results that included record sales, pump shipments and gross margin for a second quarter, while management highlighted early progress in its... 
Via MarketBeat
Topics Earnings
News headline image
TNDM Q2 Deep Dive: Pharmacy Channel Gains and Pipeline Execution Amid Margin Recovery
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $254.6... 
Via StockStory
Topics Economy
News headline image
Tandem Diabetes’s (NASDAQ:TNDM) Q2 CY2026 Earnings Results: Revenue In Line With Expectations
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 5.8% year on year to $254.6... 
Via StockStory
Topics Artificial Intelligence
News headline image
Tandem Diabetes Earnings: What To Look For From TNDM
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be announcing earnings results this Thursday after market close. Here’s what you need to ... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 Stocks Under $50 We Steer Clear Of
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have realized stron... 
Via StockStory
News headline image
1 Unprofitable Stock with Exciting Potential and 2 Facing Challenges
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks with Exciting Potential and 2 We Turn Down
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember... 
Via StockStory
News headline image
Why Tandem Diabetes (TNDM) Shares Are Sliding Today
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 2.5% in the afternoon session after a new competitor, Modular Me... 
Via StockStory
News headline image
1 Mooning Stock with Impressive Fundamentals and 2 We Find Risky
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
Topics Stocks
News headline image
Tandem Diabetes (TNDM): Buy, Sell, or Hold Post Q1 Earnings?
Tandem Diabetes has gotten torched over the last six months - since December 2025, its stock price has dropped 25.8% to $16.77 per share. This may have inves... 
Via StockStory
News headline image
Why Is Tandem Diabetes (TNDM) Stock Soaring Today
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 13.8% in the afternoon session after Wells Fargo analysts upgr... 
Via StockStory
News headline image
What to Know About This $18 Million Bet on a Rental Business With 35 Years of Dividend Growth ↗
McGrath RentCorp delivers modular buildings and equipment rentals to diverse institutional and industrial clients across multiple sectors. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f... 
Via StockStory
News headline image
3 Small-Cap Stocks We Keep Off Our Radar
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
News headline image
Tandem Diabetes’s Q1 Earnings Call: Our Top 5 Analyst Questions
Tandem Diabetes Care’s first quarter results were met with a positive market reaction, reflecting the company’s ability to exceed Wall Street’s revenue and G... 
Via StockStory
Topics Earnings
News headline image
3 Healthcare Stocks We’re Skeptical Of
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
News headline image
Tandem Diabetes Care Q1 Earnings Call Highlights ↗
Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward... 
Via MarketBeat
Topics Earnings Supply Chain
News headline image
Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today
What Happened? Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 10.9% in the afternoon session after the company's disappointing... 
Via StockStory
Topics Artificial Intelligence
News headline image
TNDM Q1 Deep Dive: Margin Expansion and Pipeline Advances Amid Business Model Shift
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 5.5% year on ... 
Via StockStory
News headline image
Tandem (TNDM) Q1 2026 Earnings Transcript ↗
Tandem (TNDM) Q1 2026 Earnings Transcript 
Via The Motley Fool
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
Via Chartmill
News headline image
Tandem Diabetes’s (NASDAQ:TNDM) Q1 CY2026: Beats On Revenue, Stock Jumps 10.9%
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 5.5% year on year to $247.... 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.